ALFYX | NRGEX | ALFYX / NRGEX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 20 years | 3 years | - |
Gain YTD | -2.254 | -2.121 | 106% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 593M | 9.89B | 6% |
Annual Yield % from dividends | 0.29 | 0.89 | 33% |
Returns for 1 year | 7.24 | 5.00 | 145% |
Returns for 3 years | 2.25 | 0.93 | 241% |
Returns for 5 years | 15.67 | N/A | - |
Returns for 10 years | -11.22 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FSKLX | 11.37 | N/A | N/A |
Fidelity SAI Intl Low Volatil Idx | |||
ETIHX | 35.38 | -0.37 | -1.03% |
Eventide Healthcare & Life Sciences I | |||
AMIDX | 13.46 | -0.15 | -1.10% |
Amana Developing World Institutional | |||
REPIX | 42.75 | -0.53 | -1.22% |
ProFunds Real Estate UltraSector Inv | |||
GSVTX | 16.33 | -0.24 | -1.45% |
Goldman Sachs Large Cap Value Inv |